Prof. Dr. med. Kilian Weigand

Berufstätigkeit

Berufliche Ausbildung/Weiterbildung

Stipendien, Auszeichnungen

• seit 01/05 Mitglied der German Association for the Study of Liver (GASL)
• seit 05/09 Mitglied der American Gastroenterology Association (AGA)
• seit 08/11 Mitglied der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS)
• seit 09/11 Mitglied der Deutschen Gesellschaft für Ultraschall in der Medizin (DEGUM)
• seit 12/12 Mitglied des Bundes Deutscher Internisten e.V.
• seit 11/15 Mitglied der Bayerischen Gastroenterologen (GfGB)
• seit 03/19 Mitglied der Deutschen Gesellschaft für Endoskopie und bildgebende
  Verfahren (DGEBV)

Liver stiffness assessed by shear-wave elastography declines in parallel with immunoregulatory proteins in patients with chronic HCV infection during DAA Therapy
Peschel G, Grimm J, Buechler C, Kammerer S, Jung EM, Werner J, Müller-Schilling M, Weigand K
Clinical Hemorheology and Microcirculation. Epub ahead of print.
[PMID: 34120896]

Liver lipids of patients with hepatitis B and C and associated hepatocellular carcinoma
Haberl EM, Weiss TS, Feder S, Peschel G, Weigand K, Köhler N, Pauling JK, Wenzel JJ, Höring M, Krautbauer S, Liebisch G, Büchler C
International Journal of Molecular Science. 2021;22:5297
[PMID: 34069902]

Lenvatinib as first-line treatment of hepatocellular carcinoma in patients with impaired liver function in advanced liver cirrhosis: real world data and experience of a tertiary hepatobiliary center
Cosma LS, Weigand K, Müller-Schilling M, Kandulski K
J Gastrointestin Liver Dis. 2021;30:1-7
[PMID: 33951122]   IF 2,351

Rapid Decline of Serum Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) in Non-Cirrhotic Patients with Chronic Hepatitis C Infection Receiving Direct-Acting Antiviral Therapy.
Grimm J, Peschel G, Müller M, Schacherer D, Wiest R, Weigand K, Buechler C.
J Clin Med. 2021;10:1621
[PMID: 33920491]   IF 3,303

Diagnostic Accuracy and Therapeutic Efficacy of Digital Single-Operator Cholangioscopy for Biliary Lesions and Stenosis
Weigand K, Küchle M, Zuber-Jerger I, Müller M, Kandulski A
Digestion. 2021;25:1-7
[PMID: 33631748]   IF 2,037

Secondary hemophagocytic lymphohistiocytosis and severe liver injury induced by hepatic SARS-CoV-2 infection unmasking M. Wilson: an unusual case
Lubnow M, Schmidt B, Fleck M, Salzberger B, Müller T, Peschel G, Schneckenpointner R, Lange T, Hitzenbichler F, Kieninger M, Lunz D, Graf B, Brochhausen C, Weber F, Lüke F, Peterhoff D, Schuster P, Offner R, Wallner S, Hanses F, Schmid S, Weigand K, Geismann F, Poeck H, Pukrop T, Evert M, Gessner A, Burkhardt R, Herr W, Maier L, Heudobler D
Int J Infect Dis. 2021;103:624-627
[PMID: 33412272]

Ribavirin Improves NK cell IFNγ Response during Sofosbuvir-based DAA Therapy of HCV-infected Liver Transplant Recipients
Adenugba A, Hornung M, Weigand K, Junger H, Lang H, Marquardt JU, Zimmermann T, Geissler EK, Schlitt HJ, Werner JM
Transplantation. 2020; Epub ahead of print.
[PMID: 33587435]

Chemerin Is a Valuable Biomarker in Patients with HCV Infection and Correlates with Liver Injury.
Peschel G, Grimm J, Gülow K, Müller M, Buechler C, Weigand K
Diagnostics (Basel). 2020 Nov;10(11):E974 [
PMID: 33228201]   IF 3,110

Definition, Reasons and Risk Factors for Mortality of Patients listed for Liver Transplantation – a Single-Center Study
Peschel G, Kraft IC, Scherer MN, Sinner B, Müller M, Weigand K
Z Gastroenterologie. 2020 Nov;58(11):1065-1073
[PMID: 33197949]  IF 1,338

Endoscopic necrosectomy of walled-off-necrosis following severe pancreatitis using the Hot Axios™ Stent – A case series
Weigand K, Mehrl A, Gössmann H, Müller M, Kandulski A
Dig Dis. 2019 Nov 14:1-4
[PMID: 31726460]   IF 2,908

Characterization of the interaction between subviral particles of hepatitis B virus and dendritic cells – in vitro study
Farag MM, Peschel G, Müller M, Weigand K
Infect Drug Resist. 2019 Oct 12:3125-3135
[PMID: 31632101]   IF 3,000

Accuracy of different rapid urease tests in comparison with histopathology in patients with endoscopic signs of gastritis
Dechant FX, Dechant R, Kandulski A, Selgrad M, Weber F, Reischl U, Wilczek W, Müller M, Weigand K
Digestion. 2019 Feb 28:1-7
[PMID: 30820016]   IF 2,037

Evaluation of two point Dixon water-fat separation for Gd-EOB-DTPA-enhanced MRI based estimation of liver function
Heimerl M, Probst U, Pölsterl S, Fellner C, Nickel D, Weigand K, Brunner S, Zeman F, Stroszczynski C, Wiggermann P
Sci Rep. 2018 Sep 8(1):13863
[PMID: 30218001]   IF 4,122

Prevalence of Hepatitis B and C from participants of a public information day in Germany
Peschel G, Müller M, Weigand K
Clin Lab. 2018 Jul 64(7):1327-1331
[30146827]   IF 1,04

Hepatitis E Seroprevalence and Genotyping in a Cohort of Wild Boars in Southern Germany and Eastern Alsace
Weigand K, Weigand K, Schemmerer M, Müller M, Wenzel JJ
Food Environ Virol. 2018 Jun 10(2):167-175
[PMID: 29214558]   IF 1,847

Cholangioscopy-guided electrohydraulic lithotripsy of large bile duct stones through a percutaneous access device
Weigand K, Kandulski A, Zuber-Jerger I, Müller M, Gössmann H
Endoscopy. 2018 May 50(5):E111-E112
[PMID: 29452436]   IF 6,107

Acute Cholecystitis: Early Versus Delayed Cholecystectomy, A Multicenter Randomized Trial (ACDC Study, NCT00447304)
Gutt CN, Encke J, Köninger J, Harnoss JC, Weigand K, Kipfmüller K, Schunter O, Götze T, Golling MT, Menges M, Klar E, Feilhauer K, Zoller WG, Ridwelski K, Ackermann S, Baron A, Schön MR, Seitz HK, Daniel D, Stremmel W, Büchler MW
Ann Surg. 2013 Sep 258(3):385-393
[PMID: 24022431]   IF 6.329

Stagnant-Loop-Syndrom als seltene Ursache einer ausgeprägten Malabsorption
Weigand K, Herfarth C, Weigand K
Viszeralmedizin. 2013 Jun;29(3):190-194

Immune tolerance against HBV can be overcome in HBV transgenic mice by immunization with Dendritic Cells pulsed by HBVsvp
Farag MM, Tedjokusumo R, Flechtenmacher C, Asen T, Stremmel W, Müller M, Protzer U, Weigand K
Vaccine. 2012 Sep 14;30(42):6034-9
[PMID:22867720]   IF 3.616

Transfusionsstrategien: Leitliniengerechte Diagnostik und Therapie
Pschowski R, Weigand K, Walther A, Hofer S
Transfusionsmedizin. CME-Thieme.de. 2012

Gastrointestinale Blutungen. Im Einsatz immer ein Notfall?
Weigand K, Dussinger R
retten! 2012;2:139-144

Vaccination with Dendritic Cells pulsed with hepatitis C pseudo particles (HCVpp) induces specific immune responses in mice
Weigand K, Voigt F, Encke J, Hoyler B, Stremmel W, Eisenbach C
W J Gastroenterol. 2012 Feb 28;18(8):785-93.
[PMID:22371638]   IF 2,240

Dendritic cells can effectively be pulsed by HBVsvp and induce specific immune reactions in mice
Farag MMS, Hoyler B, Encke J, Stremmel W, Weigand K
Vaccine. 2010 Dec 16;29(2):200-6.
[PMID:21050902]   IF 3.616

Assembly and export determine the intracellular distribution of Hepatitis B Virus core protein subunits
Weigand K, Knaust A, Schaller H
J Gen Virol. 2010 Jan;91(Pt 1):59-67.
[PMID: 19741067]   IF 3.260

Low levels of prothrombin time (INR) and platelets do not increase the risk of significant bleeding when placing central venous catheters
Weigand K, Encke J, Meyer J, Hinkel UP, Munder M, Stremmel W, Zahn A
Med Klin. 2009 May;104(5):331-5.
[PMID: 19444412]   IF 0.473

Percutaneous Liver Biopsy – Retrospective Study over 15 years comparing 287 inpatients with 428 outpatients
Weigand K, Weigand K
J Gastroenterol Hepatol. 2009 May;24(5):792-9.
[PMID: 19220661]   IF 2.317

Chronic anemia masking a primary large B-cell lymphoma of the small intestine, finally diagnosed by double-balloon enteroscopy.
Weigand K, Ganten TM, Andrulis M, Stremmel W, Sauer P, Schaible A.
Endoscopy. 2008 Sep;40 Suppl 2:E149. [PMID: 18633862]

Acute cholecystitis - early laparoskopic surgery versus antibiotic therapy and delayed elective cholecystectomy: ACDC-study.
Weigand K, Köninger J, Encke J, Büchler MW, Stremmel W, Gutt CN.
Trials. 2007 Oct 4;8:29.
[PMID: 17916243]   IF 2.02

Are heat stroke and physical exhaustion underestimated causes of acute hepatic failure?
Weigand K, Riediger C, Stremmel W, Flechtenmacher C, Encke J.
World J Gastroenterol. 2007 Jan 14;13(2):306-9.
[PMID: 17226914]